Kimberly-Clark vs Procter & Gamble KMB vs PG
Kimberly-Clark and Procter & Gamble on one sheet: valuation multiples, growth, margins, debt, dividends and returns, each section labelled with the period it covers, from the companies' filings. Add or remove a stock above the sheet; the link holds the set.
What differs most
- Market value: Procter & Gamble $370.02B, Kimberly-Clark $35.11B.
- Price / sales: Procter & Gamble 4.3×, Kimberly-Clark 2.2×.
- One-year price return: Procter & Gamble +6.5%, Kimberly-Clark −11.8%.
- Operating margin: Procter & Gamble 22.7%, Kimberly-Clark 15.0%.
Price return
2025-10-16 → 2026-10-16
KMB−11.8%
PG+6.5%
Profile
latestSector
Consumer Defensive
Consumer Defensive
Industry
Household & Personal Products
Household & Personal Products
Market value
$35.11B
$370.02B
Enterprise value
$40.67B
$394.74B
Employees
36,000
104,000
Revenue per employee (TTM)
$439K
$837K
Our models
nightlythe valuation on each stock's pagePrice vs model
11% undervalued vs model
32% overvalued vs model
Model range
$64.47–324
$73.70–333
Models in the headline
1
1
FCF growth priced in, at a 10% return
13.8%
14.3%
Every model, its assumptions and its range: KMB valuation · PG valuation. The growth priced in, at any return: KMB reverse DCF · PG reverse DCF.
Trading
close 2026-10-16Last close
$105.57
$159.35
52-week high
$121.44
$167.20
52-week low
$93.05
$138.04
Price vs 52-week high
−13.1%
−4.7%
Price vs 52-week low
+13.5%
+15.4%
Average daily volume / shares
1.3%
0.4%
Beta
0.28
0.38
Returns
to 2026-10-161 month
+7.6%
+8.4%
3 months
−3.1%
+5.2%
6 months
+7.8%
+11.3%
Year to date
+4.6%
+11.2%
1 year
−11.8%
+6.5%
1 year, dividends added
−7.5%
+9.4%
2 years
−27.7%
−7.6%
Valuation
KMB price × TTM to Jun 2026 · PG price × FY2026P/E (TTM)
18.0×
24.1×
P/E on consensus EPS (next FY)
14.4×
22.9×
Price / sales
2.2×
4.3×
EV / sales
2.6×
4.5×
EV / EBITDA
—
17.2×
Price / book
20.1×
—
Price / free cash flow (FY)
21.4×
24.4×
Free-cash-flow yield (FY)
4.7%
4.1%
Growth
KMB TTM and FY2025 · PG TTM and FY2026Revenue growth (TTM)
—
+0.4%
Revenue growth, consensus next FY
+0.8%
+2.0%
Revenue, 3-year CAGR
−6.6%
2.0%
Revenue, 5-year CAGR
−3.0%
2.7%
EPS growth (TTM)
—
−3.2%
EPS growth, consensus next FY
+20.9%
+5.3%
EPS, 3-year CAGR
2.0%
3.9%
Free cash flow, 3-year CAGR
−4.1%
3.2%
Diluted shares, 3-year change
−1.5%
−2.5%
Profitability
KMB TTM to Jun 2026 · PG FY2026Gross margin (FY)†
35.6%
50.2%
Operating margin
15.0%
22.7%
EBITDA margin
—
26.3%
Net margin
12.4%
18.4%
Free-cash-flow margin (FY)
10.0%
17.4%
Return on equity
111.7%
—
Return on assets
10.5%
12.5%
Asset turnover
0.85
0.68
† Gross margin (FY): As filed. Companies draw the cost-of-revenue line in different places, so gross margins of two companies in one industry can differ for that reason alone; operating margin does not depend on where the line is drawn.
Balance sheet
KMB MRQ Jun 2026 · PG MRQ Mar 2026Cash
$956.0M
$12.31B
Total debt
$6.52B
$37.03B
Net debt
$5.56B
$24.72B
Debt / equity
3.7×
—
Net debt / EBITDA (TTM)
—
1.1×
Interest coverage (FY)
9.7×
22.5×
Current ratio (FY)
0.75
0.68
Dividends
trailing 12 monthsDividend yield
4.8%
2.7%
Dividends per share
$5.10
$4.29
Payout ratio (of TTM EPS)
86.7%
64.8%
Dividend per share, 5-year CAGR
2.6%
5.3%
Frequency
Quarterly
Quarterly
Ownership and activity
last 90 days · latest 13FTracked superinvestors holding (13F)
2
10
Insider open-market buys (Form 4)
$0
$0
Insider sales (Form 4)
$0
$1.2M
Analyst upgrades
0
1
Analyst downgrades
0
2
Statements
KMB income TTM to Jun 2026 · cash flow FY2025 · PG income FY2026 · cash flow FY2026Revenue
$15.80B
$87.03B
EBITDA
—
$22.91B
Operating income
$2.38B
$19.75B
Net income
$1.96B
$16.05B
EPS (diluted)
$5.88
$6.62
Operating cash flow
$2.78B
$19.56B
Capital expenditure
−$1.14B
−$4.41B
Free cash flow
$1.64B
$15.15B
Dividends paid
$1.66B
$10.23B
Statements from the companies' SEC filings; prices, dividends and consensus estimates from Financial Modeling Prep; insider trades from Form 4 and holdings from 13F. Refreshed nightly. A comparison of filed numbers, not a recommendation to buy, sell or hold any security.